While numerous nanoparticle vaccines against influenza have been proposed to date, this methodology includes the advantages of rapid integration and co-display of HA and NA antigens as well as the co-delivery of lipid adjuvants including PHAD and QS21. This evidence concerns the gene XK and influenza.